M Tiseo1, V Franciosi, A Ardizzoni. Show Affiliations » 1. Oncologia Medica, Azienda Ospedaliera-Universitaria, Parma, Italy.
Abstract
Entities: Chemical
Mesh： See more » Angiogenesis Inhibitors/administration & dosageAntineoplastic Combined Chemotherapy ProtocolsBenzenesulfonates/administration & dosageCarcinoma, Non-Small-Cell Lung/drug therapyErbB Receptors/antagonists & inhibitorsHumansIndoles/administration & dosageLung Neoplasms/drug therapyMedical OncologyNiacinamide/analogs & derivativesPhenylurea CompoundsPiperidines/administration & dosageProtein Kinase Inhibitors/administration & dosagePyridines/administration & dosagePyrroles/administration & dosageQuinazolines/administration & dosageSorafenibSunitinib
Substances： See more » Angiogenesis InhibitorsBenzenesulfonatesIndolesPhenylurea CompoundsPiperidinesProtein Kinase InhibitorsPyridinesPyrrolesQuinazolinesNiacinamideSorafenibErbB ReceptorsSunitinibvandetanib
Year: 2006 PMID： 16608985 DOI： 10.1093/annonc/mdj924
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976